Leonardo Scapozza is a prominent academic leader based in Geneva, currently serving as the Interim CFO and Co-Founder of Adoram Therapeutics. He has a strong background in finance and strategic management, contributing significantly to the growth of innovative therapeutic solutions. In addition to his role at Adoram, he is affiliated with the University of Geneva, where he engages in research and mentorship. Scapozza's expertise and leadership are instrumental in bridging academia and industry in the field of biotechnology.